ArticleAdvanced healthcare materials2026
A Muscle-Mimetic Core-Sheath Composite Yarn Scaffold for In-Body Tissue Induction and Regeneration of Small-Diameter Vascular Grafts.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Cardiovascular diseases remain a leading cause of mortality worldwide. Small-diameter vascular grafts (SDVGs) continue to face critical clinical challenges, including acute thrombosis, intimal hyperplasia, and insufficient endothelialization. Inspired by the hierarchical structure of skeletal muscle, in which myofibrils assemble into muscle fibers and then into functional tissue, we developed a novel tissue-engineered vascular graft (TEVG) based on a muscle-mimetic composite yarn. Using friction spinning technology, we fabricated a core-sheath composite yarn with a poly(ethylene terephthalate) (PET) filament as the artificial myofibril core to provide durable mechanical support, and poly(glycolic acid) (PGA) staple fibers as the sheath component to replicate the extracellular matrix (ECM) topology of muscle fibers, thereby enhancing bioactivity. The knitted tubular scaffold was implanted subcutaneously in rabbits for in vivo tissue induction, followed by decellularization, yielding an extracellular matrix-rich and biocompatible graft. This "yarn mimicking muscle, fabric transforming into vessel" strategy achieved staged vascular regeneration. In a canine carotid artery replacement model, the TEVG maintained 100% patency at one month, with histological evidence of endothelialization (CD31+), smooth muscle regeneration (α-SMA+), and collagen deposition. This bioinspired approach demonstrates short-term feasibility for small-diameter vascular regeneration in a canine model, providing a promising platform for long-term studies and clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.